Egg Bio-Tech Co.

("Egg Bio", stock code 603387), founded in 2002, is a biotechnology enterprise focusing on the research and development, production, sales and service of in vitro diagnostic reagents and instruments. After years of precipitation, it was successfully listed on the main board of SSE in July 2017, and its business has spread to more than 110 countries and regions around the world.

EcoGreen has made a breakthrough with the localized immediate detection of cardiac troponin I (POCT), and gradually completed the balanced development of the whole industrial chain. Guided by clinical needs and driven by scientific and technological innovation, we have established eight technology platforms including POCT, chemiluminescence, biochemical testing, molecular testing, thrombosis and hemostasis testing, hematology testing, urinalysis, and raw materials for quality-controlled diagnostics through continuous independent research and development and technological breakthroughs, and have built a product system that is based on the POCT line, and is based on the chemiluminescence, coagulation, pipeline, and molecular. The product system covers POCT, biochemistry and immunity, blood cell analysis, thrombosis and hemostasis, covering cardiovascular, inflammation, renal, metabolic, hormonal, glucose metabolism, oncology, blood cell, blood coagulation, etc. The application scenarios of the products include laboratory departments of all levels of healthcare institutions, emergency rooms, health checkup centers, community outpatient clinics, and personal health management at home. After passing the ISO13485 certification audit in 2010, we have completed the introduction of the requirements of the quality system regulations of five countries, including the U.S. FDA, Japan, Brazil, Canada, and Australia, and obtained the MDSAP certificate, and participated in the inter-room quality assessment EQA of the Clinical Laboratory Center of the Ministry of Health for many years in a row and obtained the certificate.

Adhering to the service concept of "after-sales service standardization, refinement, timeliness and professionalism", we have set up 28 after-sales engineers stationed at service outlets across the country, opened a 24-hour toll-free after-sales hotline, and established a perfect after-sales service system and feedback mechanism to ensure that the customer's problematic equipment can be restored to use within 24 hours.

Pursuing excellence and delivering health, the company takes "aspire to become an internationally competitive biotechnology enterprise" as its development vision, and actively lays out its global development. At present, the company's headquarter covers an area of more than 150 acres, establishing a large-scale garden ecological plant, and more than 35 subsidiaries around the world, with business radiating all over the world. As a post-doctoral innovation and practice base in Jiangsu Province, Egg Bio actively recruits high-quality talents and focuses on talent cultivation, with a total of more than 2,500 employees, and is contributing to the cause of human health with more than 30,000 partners.